Transcutaneous Breast Cancer Diagnosis by Canine Odorology

Exclusion Criteria

• •1. Patient with bilateral breast lesions classified as BI-RADS® category 4 or 5;
• •2. Patient with breast implant(s);
• •3. Patient with a personal history of breast surgery for benign lesion(s) of the concerned breast operated less than 4 weeks before the date of inclusion in this study;
• •4. Patient with a personal history of cancer (in situ or invasive) less than 5 years before inclusion whatever the anatomical site including cutaneous basal cell carcinoma;
• •5. Patient with a personal history of punctures and/or percutaneous breast biopsies of the concerned breast less than 4 weeks before inclusion;
• •6. Patient with a breast skin ulceration;
• •7. Patient under insulin (risk of sudation that may impair compress sample);
• •8. Concomitant antibiotics or corticoids taken one week before inclusion in the study;
• •9. Patient with a current viral infection (fever);
• •10. Persons under guardianship or deprived of liberty;
• •11. Impossibility to submit to the medical monitoring expected by the study for geographical or severe psychological reasons.